US U-Turn on COVID IP Waiver Alone Will Not Solve Vaccine Crisis – Intellectual Property Is an Important Part of the Debate, but Greater Transparency Is Required

A shortened and edited version of this opinion was published by The Financial Times on June 17th, 2021

2 Pages Posted: 12 Aug 2021

See all articles by Duncan Matthews

Duncan Matthews

Queen Mary University of London - School of Law

Timo Minssen

University of Copenhagen - Centre for Advanced Studies in Biomedical Innovation Law (CeBIL) - Faculty of Law

Date Written: May 2021

Abstract

The Covid response requires a toolkit of policies to ensure adequate vaccine manufacturing and delivery. The significance of IP and its interface with collaboration and knowledge transfer in responding to these challenges must be key components of that approach. Irrespective of the unsolved questions related to the US announcement and the reasons behind it, the focus on the role of IP should trigger greater transparency and further studies, more nuanced debates and more innovative approaches for tackling such challenges. This must include not only pandemic responses, but also global justice, climate change, antimicrobial resistance and the associated collective action problems.

Keywords: Health Law, Life Science Law, Covid-19, Vaccinations

Suggested Citation

Matthews, Duncan and Minssen, Timo, US U-Turn on COVID IP Waiver Alone Will Not Solve Vaccine Crisis – Intellectual Property Is an Important Part of the Debate, but Greater Transparency Is Required (May 2021). A shortened and edited version of this opinion was published by The Financial Times on June 17th, 2021, Available at SSRN: https://ssrn.com/abstract=3881020 or http://dx.doi.org/10.2139/ssrn.3881020

Duncan Matthews (Contact Author)

Queen Mary University of London - School of Law ( email )

67-69 Lincoln's Inn Fields
London, London WC2A 3JB
United Kingdom

HOME PAGE: http://https://www.qmul.ac.uk/law/people/academic-staff/

Timo Minssen

University of Copenhagen - Centre for Advanced Studies in Biomedical Innovation Law (CeBIL) - Faculty of Law ( email )

Karen Blixens Plads 16
Copenhagen, 2300
Denmark
+46 708 607517 (Phone)

HOME PAGE: http://jura.ku.dk/cebil/staff/profile/?pure=en/persons/381631

Do you have a job opening that you would like to promote on SSRN?

Paper statistics

Downloads
84
Abstract Views
546
rank
424,264
PlumX Metrics